December 18, 2025 05:47 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Indian Visa Application Centre in Dhaka shuts down early amid rising security concerns | Market update: Sensex tumbles 120 points, Nifty below 25,850 at closing bell | ‘Won’t apologise’: Prithviraj Chavan stands firm on controversial Operation Sindoor remark despite backlash | India summons Bangladesh High Commissioner after provocative 'seven sisters' remark | Amazon eyes $10 billion investment in OpenAI — a gamechanger for AI industry! | Goa nightclub fire horror: Luthra brothers brought back to India from Thailand, arrested | Messi chaos costs minister his job: Aroop Biswas resigns after Salt Lake Stadium fiasco | Bengal SIR draft list out: Around 58 lakh voters’ names dropped | Relief for Sonia, Rahul Gandhi as Delhi court refuses to act on ED chargesheet in National Herald case | Centre moves to replace MGNREGA with 'G Ram G', sets stage for winter session showdown
Handheld X-ray
Representational image by Anna Shvets on Pexels

India develops cost-effective handheld X-ray for TB screening

| @indiablooms | Oct 19, 2024, at 06:54 pm

New Delhi/IBNS: India has made a major advancement in tuberculosis (TB) diagnostics with the creation of a homegrown portable X-ray device, according to ANI.

Developed through a partnership between IIT Kanpur and the Indian Council of Medical Research (ICMR), this new device aims to boost early TB detection by providing a more affordable alternative to imported equipment.

The device costs less than half the price of international models and is designed to improve access to TB screenings, particularly for underserved communities, by offering portable and convenient testing options near patients' homes.

ICMR Director General Rajiv Bahl highlighted this innovation during the 19th International Conference of Drug Regulatory Authorities (ICDRA) INDIA-2024.

He emphasized that this new technology could have a significant impact on public health in India by enabling more widespread and timely diagnosis and treatment of TB.

Bahl also announced the creation of three Mpox testing kits, currently being produced by three different companies, as part of the country’s ongoing healthcare advancements.

The fight against sickle cell disease was another focus. India, with over a million affected individuals, has the world's second-largest population of sickle cell patients.

The ICMR Director General revealed that 18 new, low-cost tests for detecting sickle cell anemia have been developed, bringing down the cost from Rs 400 to just Rs 30 per test, making screening far more affordable.

This development aligns with the National Sickle Cell Anaemia Elimination Mission, launched by Prime Minister Narendra Modi last year, which aims to eradicate the disease as a public health issue by 2047.

In other health news, India is in the third phase of clinical trials for a dengue vaccine, according to reports.

Bahl expressed hope for positive results within a year.

If proven safe and effective, the vaccine could become a critical asset in the country’s efforts to control dengue.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.